PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,477 | -22.1% | 33,815 | +13.4% | 0.00% | – |
| Q2 2023 | $134,185 | +94.5% | 29,819 | +196.7% | 0.00% | – |
| Q1 2022 | $69,000 | -76.2% | 10,050 | +8.4% | 0.00% | – |
| Q3 2021 | $290,000 | +15.5% | 9,275 | +5.7% | 0.00% | – |
| Q2 2021 | $251,000 | -40.1% | 8,775 | -9.2% | 0.00% | -100.0% |
| Q1 2021 | $419,000 | -38.7% | 9,661 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $683,000 | – | 9,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |